Immunology and immunotherapy approaches for prostate cancer
/in International Publications, Prostate Cancer /von 2007-04-10 / Prostate Cancer Prostatic Dis. 2007;10(3):224-36Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia
/in Chronic Leukemia, International Publications /von 2007-04-04 / Br. J. Haematol. 2007 May;137(4):297-306Use of interferon-alpha-induced dendritic cells in the therapy of patients with malignant brain gliomas
/in Glioblastoma, International Publications /von 2007-04-01 / Bull. Exp. Biol. Med. 2007 Apr;143(4):528-34Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model
/in Glioblastoma, International Publications /von 2007-04-01 / J. Neurosurg. 2007 Apr;106(4):638-45Dendritic cell-based active specific immunotherapy for malignant glioma
/in Glioblastoma, International Publications /von 2007-04-01 / Expert Opin Biol Ther 2007 Apr;7(4):439-48Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells–a pilot study
/in International Publications, Prostate Cancer /von 2007-04-01 / Prostate 2007 Apr;67(5):500-8In vitro induction of apoptosis in tumor cells by inactivated NDV and IAV
/in International Publications, Newcastle Disease Virus /von 2007-04-01 / Cancer Biother. Radiopharm. 2007 Apr;22(2):200-5Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model
/in International Publications, Pancreatic Cancer /von 2007-03-29 / Gut 2007 Sep;56(9):1275-82Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells
/in Chronic Virus Hepatitis, International Publications /von 2007-03-15 / Clin. Exp. Immunol. 2007 Jun;148(3):494-500
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de